15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.

15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
复制标题

DOI:
10.1038/onc.2013.69
复制
发表时间:
2014-02-27
期刊:
影响因子:
8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

15-羟基前列腺素脱氢酶(15-hydroxyprostaglandin dehydrogenase, 15-PGDH)是前列腺素代谢的关键酶。本研究为15-PGDH通过15-keto-PGE2/PPARγ/p21WAF1/Cip1信号通路抑制肝细胞癌(HCC)生长提供了重要证据。强制过表达15-PGDH抑制HCC细胞的体外生长,而敲低15-PGDH则增强肿瘤生长参数。在SCID小鼠肿瘤异种移植模型中,接种过表达15-PGDH的人HCC细胞(Huh7)可显著抑制肿瘤生长,而敲低15-PGDH可促进肿瘤生长。在将小鼠肝癌细胞(Hepa1-6)接种于同源C57BL/6小鼠的单独肿瘤移植模型中,瘤内注射表达15-PGDH的腺病毒载体(pAd-15-PGDH)可显著抑制异种移植肿瘤的生长。15-PGDH的抗肿瘤作用是通过其酶促产物15-酮- pge2介导的,其作为内源性PPARγ配体。15- pgdh衍生的15-keto-PGE2激活PPARγ增强了PPARγ与p21WAF1/Cip1启动子的关联,增加了p21的表达以及与CDK2、CDK4和PCNA的关联。shRNA缺失p21可逆转15- pgdh诱导的肝癌细胞生长抑制;p21过表达可阻止15-PGDH敲低诱导的肿瘤细胞生长。这些结果表明,关键的15-PGDH/15-keto- pge2介导的PPARγ和p21WAF1/Cip1信号级联激活调节肝癌发生和肿瘤进展。
15-hydroxyprostaglandin dehydrogenase (15-PGDH) is a key enzyme in prostaglandin metabolism. This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-PGE2/PPARγ/p21WAF1/Cip1 signaling pathway. Forced overexpression of 15-PGDH inhibited HCC cell growth in vitro, whereas knockdown of 15-PGDH enhanced tumor growth parameters. In a tumor xenograft model in SCID mice, inoculation of human HCC cells (Huh7) with overexpression of 15-PGDH led to significant inhibition of tumor growth, while knockdown of 15-PGDH enhanced tumor growth. In a separate tumor xenograft model in which mouse HCC cells (Hepa1-6) were inoculated into syngeneic C57BL/6 mice, intratumoral injection of adenovirus vector expressing 15-PGDH (pAd-15-PGDH) significantly inhibited xenograft tumor growth. The anti-tumor effect of 15-PGDH is mediated through its enzymatic product, 15-keto-PGE2, which serves as an endogenous PPARγ ligand. Activation of PPARγ by 15-PGDH-derived 15-keto-PGE2 enhanced the association of PPARγ with the p21WAF1/Cip1 promoter and increased p21 expression and association with CDK2, CDK4 and PCNA. Depletion of p21 by shRNA reversed 15-PGDH-induced inhibition of HCC cell growth; overexpression of p21 prevented 15-PGDH knockdown-induced tumor cell growth. These results demonstrate a key 15-PGDH/15-keto-PGE2-mediated activation of PPARγ and p21WAF1/Cip1 signaling cascade that regulates hepatocarcinogenesis and tumor progression.
DOI: 10.1053/j.gastro.2011.12.061
发表时间: 2012-05
期刊: Gastroenterology
影响因子: 29.4
作者:
El-Serag HB
通讯作者: El-Serag HB
DOI: 10.1158/1535-7163.mct-09-0551
发表时间: 2009-11
影响因子: 5.7
作者:
Lim K;Han C;Dai Y;Shen M;Wu T
通讯作者: Wu T
DOI: 10.1002/hep.22506
发表时间: 2008-10
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Llovet, Josep M.;Bruix, Jordi
通讯作者: Bruix, Jordi
DOI: 10.1038/375159a0
发表时间: 1995-05-11
期刊: NATURE
影响因子: 64.8
作者:
LUO, Y;HURWITZ, J;MASSAGUE, J
通讯作者: MASSAGUE, J
DOI: 10.1016/s0016-5085(99)70020-x
发表时间: 1999-05-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Bosch-Marcé, M;Clària, J;Rodés, J
通讯作者: Rodés, J